# Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke

> **NCT04280003** · PHASE2 · UNKNOWN · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 30 (estimated)

## Conditions studied

- Ischemic Stroke
- Adipose Tissue-derived Stem Cell
- Functional Status

## Interventions

- **OTHER:** Alogenic adipose tissue-derived stem cells
- **DRUG:** Placebo solution

## Key facts

- **NCT ID:** NCT04280003
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-20
- **Primary completion:** 2023-07-15
- **Final completion:** 2023-07-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04280003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04280003, "Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04280003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*